PVI
MGNX icon

Pura Vida Investments’s MacroGenics MGNX Stock Holding History

Pura Vida Investments’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-175,000
Closed -$5.57M – 258
2021
Q1 		$5.57M Buy
+175,000
New +$4.25M 0.16% 114
2019
Q2 		– Sell
-13,500
Closed -$243K – 115
2019
Q1 		$243K Buy
+13,500
New +$233K 0.03% 101

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Pura Vida Investments's MGNX Position: Q4 2022 in Review

Pura Vida Investments sold out of MacroGenics (MGNX) in Q4 2022, closing a stake of 52,573 shares — an estimated $182K sold.

Pura Vida Investments first reported a position in MGNX in Q1 2021 and held it in 2 quarters. The position peaked at $2.19M in Q1 2021. 135 funds tracked by Wall St. Rank hold MGNX as of Q4 2022.

  • Pura Vida Investments reported no remaining MacroGenics position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 52,573 MacroGenics shares in Q4 2022, an estimated $182K.
  • Pura Vida Investments first reported a position in MacroGenics in Q1 2021 and held it in 2 quarters.
  • Pura Vida Investments's MacroGenics position peaked at $2.19M in Q1 2021.
  • 135 funds tracked by Wall St. Rank held MacroGenics as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.